Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effect of Chronic Low Dose Aspirin on Platelet and Vascular Eicosanoid Metabolism in Nonhuman Primates (Macaca fascicularis)

Effect of Chronic Low Dose Aspirin on Platelet and Vascular Eicosanoid Metabolism in Nonhuman... It has been suggested that inhibition of platelet cyclooxygenase by chronic low dose aspirin may spare vascular prostacyclin production. Conventional doses of aspirin (>5 mglkg) have been shown to inhibit the generation of both thromboxane A2and prostacyclin. Low dose aspirin inhibits prostacyclin production by excised human venous tissue, thus questioning the selectivity of such regimens. However, many clinical and surgical conditions requiring platelet inhibition involve the arterial system. We have studied the effects of various aspirin regimens on platelet, venous, and arterial cyclooxygenase activity in a nonhuman primate (Macaca fascicularis). We determined the lowest chronic dose of oral aspirin required to effectively inhibit platelet cyclooxygenase and aggregation to be 1 mglkg. After 14 days of 0, 1, or 2 mglkg aspirin, intact veins and arteries were surgically removed and perfused, and luminal prostacyclin (6-keto-PGF1α,) generation was assessed. Levels of 6-keto-PGF1α in venous perfusates were reduced by 89% and 86% (p>0.05) after 1 and 2 mglkg, respectively. Arterial 6-keto-PGF1α levels were unchanged by 1 mg/kg aspirin, but after 2 mglkg were reduced by 66% (p>0.05). Preferential inhibition of platelet over arterial cyclooxygenase is thus achievable, but only over a narrow dose range. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

Effect of Chronic Low Dose Aspirin on Platelet and Vascular Eicosanoid Metabolism in Nonhuman Primates (Macaca fascicularis)

Loading next page...
 
/lp/wolters-kluwer-health/effect-of-chronic-low-dose-aspirin-on-platelet-and-vascular-eicosanoid-lGIE1af0RV
Copyright
© 1987 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

It has been suggested that inhibition of platelet cyclooxygenase by chronic low dose aspirin may spare vascular prostacyclin production. Conventional doses of aspirin (>5 mglkg) have been shown to inhibit the generation of both thromboxane A2and prostacyclin. Low dose aspirin inhibits prostacyclin production by excised human venous tissue, thus questioning the selectivity of such regimens. However, many clinical and surgical conditions requiring platelet inhibition involve the arterial system. We have studied the effects of various aspirin regimens on platelet, venous, and arterial cyclooxygenase activity in a nonhuman primate (Macaca fascicularis). We determined the lowest chronic dose of oral aspirin required to effectively inhibit platelet cyclooxygenase and aggregation to be 1 mglkg. After 14 days of 0, 1, or 2 mglkg aspirin, intact veins and arteries were surgically removed and perfused, and luminal prostacyclin (6-keto-PGF1α,) generation was assessed. Levels of 6-keto-PGF1α in venous perfusates were reduced by 89% and 86% (p>0.05) after 1 and 2 mglkg, respectively. Arterial 6-keto-PGF1α levels were unchanged by 1 mg/kg aspirin, but after 2 mglkg were reduced by 66% (p>0.05). Preferential inhibition of platelet over arterial cyclooxygenase is thus achievable, but only over a narrow dose range.

Journal

ArteriosclerosisWolters Kluwer Health

Published: Nov 1, 1987

There are no references for this article.